From an aesthetic perspective, this matters because: GLP-1 RAs influence body composition, reducing lean mass, which might alter diffusion or uptake of injectables They impact systemic metabolism which may alter the pharmacokinetics or pharmacodynamics of other drugs As more patients on GLP-1 therapy request cosmetic injectables, including botulinum toxin, the potential for interaction becomes clinically relevant
Rauwolscine (-yohimbine) Found in hardcore fat burners
Grapefruit can interact with certain medications by affecting their metabolism in the body
The age range in UC patients was 18-64 yr while in controls 20-64 yr
a more favorable option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS Reference: rxlist.com (Tanzeum) Dulaglutide Drug Name: Trulicity (FDA Approved 9/18/14) GLP-1 receptor agonist, hypoglycemic Pharmacokinetics: Long acting (half life: 5 days) subcutaneous pen injections weekly dosing (vs daily dosing for some other GLP-1 agonists such as exenatide, liraglutide & lixisenatide) a more favorable dosing option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Finally, the role of GLP-1 in CSF secretion was overviewed because recent literature points to its clinical employment in treating IIH